Regarding miR-133a in human cancers, our previous studies demonstrated that miR-133a functions as a tumor suppressor and targets multiple oncogenes, such as FSCN1[12,13,21], LASP1 [22], CAV1 [23] and GSTP1 [24,25]. The gene discussed is CAV1; the disease is neoplasm.